Jan De Witte - 18 Jan 2023 Form 4 Insider Report for INTEGRA LIFESCIENCES HOLDINGS CORP (IART)

Role
President & CEO, Director
Signature
/s/ Eric Schwartz; Attorney-in-Fact
Issuer symbol
IART
Transactions as of
18 Jan 2023
Net transactions value
-$23,610
Form type
4
Filing time
19 Jan 2023, 15:17:02 UTC
Previous filing
21 Nov 2022
Next filing
15 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IART Common Stock Options Exercise $0 +431 $0.000000 431 18 Jan 2023 Direct
transaction IART Common Stock Tax liability $23,610 -431 -100% $54.78 0 18 Jan 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IART Restricted Stock Units Options Exercise $0 -431 -0.58% $0.000000 74,025 18 Jan 2023 Common Stock 431 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The award was a restricted stock unit award which vests in three annual equal installments on the first, second and third anniversaries of the grant date of 1/18/2022 of which the first installment vested on 1/18/2023 and which shall be delivered to Mr. De Witte within 30 days following the first business day that occurs immediately following the six-month period after the date of his separation of service as deferred compensation.